Related Experiment Video
Updated: May 11, 2026
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.
Patrick W O'Donnell1, J Carlos Manivel, Edward Y Cheng
1Department of Orthopaedic Surgery, Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA, patrick.odonnell@uky.edu.
Clinical Orthopaedics and Related Research
|May 4, 2013
Summary
Neoadjuvant chemotherapy promotes pseudocapsule formation in soft tissue sarcomas, reducing malignant cells at the tumor boundary. This may explain chemotherapy's clinical effectiveness in treating these tumors.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Research
Background:
- Soft tissue sarcomas are a diverse group of cancers.
- Standard treatment involves surgery and adjuvant therapy, but neoadjuvant chemotherapy's role is debated.
Purpose of the Study:
- Define pseudocapsule histology in soft tissue sarcomas.
- Compare pseudocapsules in chemotherapy-treated versus untreated sarcomas.
- Evaluate chemotherapy's impact on tumor cells at the host-sarcoma interface.
Main Methods:
- Histological analysis of 28 high-grade extremity soft tissue sarcomas treated with chemotherapy and surgery.
- Comparison with 47 control subjects treated with surgery alone.
- AJCC stage III, >5 cm tumors were analyzed.
Main Results:
- A two-layered pseudocapsule was common, with distinct histological features.
- Chemotherapy-treated sarcomas more frequently showed continuous, thicker, and better-developed pseudocapsules.
- Chemotherapy reduced malignant cells within and beyond the pseudocapsule.
Conclusions:
- Neoadjuvant chemotherapy aids pseudocapsule development in soft tissue sarcomas.
- Chemotherapy decreases the presence of malignant cells at the host-sarcoma interface.
- Findings offer a potential histological basis for chemotherapy's efficacy in soft tissue sarcoma treatment.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...